ストックスクリーナーアプリを入手
4.38
0.46%
0.02
アフターアワーズ：
4.34
-0.04
-0.91%
前日終値:
$4.36
開ける：
$4.35
24時間の取引高:
37,784
Relative Volume:
0.70
時価総額：
$37.05M
収益：
-
当期純損益:
$-23.81M
株価収益率:
-1.5177
EPS:
-2.8859
ネットキャッシュフロー:
$-17.01M
1週間 パフォーマンス:
-0.23%
1か月 パフォーマンス:
+22.69%
6か月 パフォーマンス:
-56.68%
1年 パフォーマンス:
-39.52%
1日の値動き範囲:
$4.1401
$4.4462
1週間の範囲:
$3.8881
$4.5359
52週間の値動き範囲:
$1.98
$13.48
Cel-Sci Corp. Stock (CVM) Company Profile
名前
Cel-Sci Corp.
セクター
電話
703-506-9460
住所
8229 Boone Boulevard, Suite 802, Vienna, VA
Compare CVM vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVM
Cel-Sci Corp.
|
4.38 | 36.88M | 0 | -23.81M | -17.01M | -2.8859 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Cel-Sci Corp. Stock (CVM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2020-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2015-03-02 | 開始されました | Dawson James | Buy |
Cel-Sci Corp. (CVM) 最新ニュース
Insider Sell: Does CEL SCI Corporation stock have upside surprise potential2026 Trade Ideas & Safe Entry Point Identification - baoquankhu1.vn
INMB.O PE Ratio & Valuation, Is INMB.O Overvalued - Intellectia AI
XCUR Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
CVM Technical Analysis & Stock Price Forecast - Intellectia AI
[Form 4] CEL SCI CORP Insider Trading Activity - Stock Titan
CEL-SCI (CVM) CFO awarded 1,336 Common Stock shares in Form 4 filing - Stock Titan
CEL SCI (CVM) CEO awarded 1,682 shares of common stock - Stock Titan
CEO Moves: Is CEL SCI Corporation stock undervalued right nowTrade Risk Summary & Weekly High Momentum Picks - baoquankhu1.vn
If You Invested $1,000 in Adicet Bio Inc (ACET) - Stock Titan
If You Invested $1,000 in CEL-SCI Corp (CVM) - Stock Titan
Trading Action: Is CEL SCI Corporation a strong candidate for buy and hold2026 Snapshot & Entry Point Confirmation Signals - baoquankhu1.vn
Why did CVM shares rally over 7% today? - MSN
CVM PE Ratio & Valuation, Is CVM Overvalued - Intellectia AI
CEL-SCI's Multikine Therapy Nears Critical Regulatory Milestones () - aktiencheck.de
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Volume Recap: Is Regencell Bioscience Holdings Limited stock a smart retirement pickJuly 2025 Macro Moves & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Why DID CVM Shares Rally Over 7% Today? - Stocktwits
Cel-Sci (CVM) Reports Narrower Q1 Net Loss - GuruFocus
CEL-SCI Reports Fiscal First Quarter 2026 Results - Investing News Network
Cancer therapy lifted 5-year survival to 73% in trial; next test in 2026 - Stock Titan
Cel-Sci: Fiscal Q1 Earnings Snapshot - kens5.com
Cel-Sci: Overview of First Fiscal Quarter Financial Results - Bitget
CEL SCI CORP SEC 10-Q Report - TradingView
Big Money Moves: Does CEL SCI Corporation stock have upside surprise potential - baoquankhu1.vn
Investment Review: Is CEL SCI Corporation trading at a discountJuly 2025 Snapshot & Comprehensive Market Scan Reports - baoquankhu1.vn
IPO Launch: Is CEL SCI Corporation trading at a discountWeekly Trading Summary & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.9% – Should You Sell? - Defense World
Kersten Geert buys Cel Sci (CVM) shares worth $200000 By Investing.com - Investing.com Australia
Insider Buying: Geert Kersten Acquires Additional Shares of CEL-SCI Corp (CVM) - GuruFocus
Kersten Geert buys Cel Sci (CVM) shares worth $200000 - Investing.com
Profit Recap: Does CEL SCI Corporation stock have upside surprise potentialWeekly Investment Report & Stepwise Trade Signal Implementation - baoquankhu1.vn
Cel Sci (CVM) Options Delisting Set for January 20th - GuruFocus
Surprises Report: Why CEL SCI Corporation stock could outperform in 2025M&A Rumor & AI Enhanced Trading Alerts - Bộ Nội Vụ
Cel-Sci (NYSEAMERICAN:CVM) Stock Price Down 6.5% – What’s Next? - Defense World
Cel-Sci Corporation (CVM) Investor Outlook: Exploring A Potential 625% Upside - DirectorsTalk Interviews
Is CEL SCI Corporation stock dividend yield sustainable2025 Geopolitical Influence & Long-Term Safe Investment Ideas - Улправда
Is CEL SCI Corporation stock positioned well for digital economyJuly 2025 Selloffs & Expert Curated Trade Setup Alerts - Улправда
Is CEL SCI Corporation stock a contrarian buyPortfolio Performance Summary & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Cel-sci-sci Corp : Dutton Associates Announces Investment Opinion - marketscreener.com
CEL-SCI (CVM) Chief Scientific Officer reports purchase of 456 shares - Stock Titan
CEL-SCI (CVM) CFO Patricia Prichep reports insider stock purchase - Stock Titan
CEL-SCI Corp (CVM) CEO and Director reports purchase of 998 shares - Stock Titan
Cel-Sci Corporation (CVM) Stock Analysis: Exploring a Potential 707% Upside with Innovative Cancer Therapies - DirectorsTalk Interviews
Cel-Sci (CVM) Reduces R&D Costs and Narrows Net Loss in FY 2025 - GuruFocus
Cancer drug Multikine nears final U.S. trial, seeks Saudi breakthrough status - Stock Titan
CEL SCI CORP SEC 10-K Report - TradingView — Track All Markets
CEL-SCI Reports Fiscal 2025 Results - Yahoo Finance
CEL-SCI (NYSE American: CVM) details Multikine survival data and cash outlook - Stock Titan
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Why CEL SCI Corporation stock is rated strong buyWeekly Risk Report & Safe Swing Trade Setups - Улправда
Cel-Sci Corp. (CVM) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):